Justin de Brabander

8.1k citations

21 papers · 270 indexed · h-index 11

Co-authors: Tom van der Poll JanWillem Duitman Lieuwe D. J. Bos W. Joost Wiersinga L.S. Boers Annemarie E. Engström Marcel A.M. Beijk Dagmar M. Ouweneel
Topics: COVID-19 Clinical Research Studies (9 papers)Respiratory viral infections research (4 papers)Pneumonia and Respiratory Infections (4 papers)
Cited by: Applied Microbiology and Biotechnology Emergency Medicine Critical Care and Intensive Care Medicine
Journals: PLoS ONE American Journal of Respiratory and Critical Care Medicine Frontiers in Immunology
Partner nations: Netherlands France United States

In The Last Decade

Justin de Brabander

19 papers receiving 266 citations

Peers

Countries citing papers authored by Justin de Brabander

Since Specialization

Citations

This map shows the geographic impact of Justin de Brabander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin de Brabander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin de Brabander more than expected).

Fields of papers citing papers by Justin de Brabander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin de Brabander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin de Brabander. The network helps show where Justin de Brabander may publish in the future.

Co-authorship network of co-authors of Justin de Brabander

This figure shows the co-authorship network connecting the top 25 collaborators of Justin de Brabander. A scholar is included among the top collaborators of Justin de Brabander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin de Brabander. Justin de Brabander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cytomegalovirus reactivation and the host immune response in patients with sepsis 2025 ·Journal of Infection ·Justin de Brabander,David S. Y. Ong,Olaf L. Cremer,Lieuwe D. J. Bos,(unknown),Diederik van de Beek	0
2	The blood transcriptional response in patients developing intensive care unit-acquired pneumonia 2025 ·European Respiratory Journal ·Justin de Brabander,(unknown),Joe M. Butler,Tom D. Y. Reijnders,Tjitske S. R. van Engelen,(unknown),Fleur P. Paling,(unknown),Daoud Sie,Richard Boyer,Timothy E. Sweeney,Marc J. M. Bonten,Leen Timbermont,Surbhi Malhotra‐Kumar,Jan Kluytmans,Hessel Peters‐Sengers,Tom van der Poll	1
3	The Plasma Proteome in Community-acquired Pneumonia: Pathophysiology, Outcome, and 10-Year Risk 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown),Hessel Peters‐Sengers,Justin de Brabander,Alex R. Schuurman,Tom D. Y. Reijnders,Bastiaan W. Haak,Xanthe Brands,(unknown),Daniel Faber,Olaf L. Cremer,Renée A. Douma,Alex F. de Vos,W. Joost Wiersinga,Joe M. Butler,Tom van der Poll	1
4	Differential platelet protein release profiles in community-acquired pneumonia and COVID-19 2025 ·ERJ Open Research ·Osoul Chouchane,Valentine Léopold,(unknown),Justin de Brabander,(unknown),A. Klarenbeek,W. Joost Wiersinga,Cornelis van ′t Veer,Tom van der Poll	2
5	Proteomic profiling of neutrophils and plasma in community-acquired pneumonia reveals crucial proteins in diverse biological pathways linked to clinical outcome 2024 ·Frontiers in Immunology ·(unknown),Osoul Chouchane,Justin de Brabander,Alex F. de Vos,Daniel Faber,Renée A. Douma,(unknown),W. Joost Wiersinga,Maartje van den Biggelaar,Tom van der Poll,Arie J. Hoogendijk	0
6	Monocyte state 1 (MS1) cells in critically ill patients with sepsis or non-infectious conditions: association with disease course and host response 2024 ·Critical Care ·(unknown),Justin de Brabander,(unknown),Joe M. Butler,Olaf L. Cremer,Brendon P. Scicluna,Timothy E. Sweeney,Miguel Reyes,Reinaldo Salomão,Hessel Peters‐Sengers,Tom van der Poll	6
7	Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality 2023 ·Thorax ·Justin de Brabander,L.S. Boers,Robert F. J. Kullberg,(unknown),Esther J. Nossent,Leo Heunks,Alexander P. J. Vlaar,Peter I. Bonta,Marcus J. Schultz,Tom van der Poll,JanWillem Duitman,Lieuwe D. J. Bos,(unknown)	15
8	Host Response Changes and Their Association with Mortality in COVID-19 Patients with Lymphopenia 2023 ·American Journal of Respiratory and Critical Care Medicine ·(unknown),Brent Appelman,Justin de Brabander,Rombout B. E. van Amstel,(unknown),Osoul Chouchane,Tom D. Y. Reijnders,Alex R. Schuurman,(unknown),(unknown),Renée A. Douma,Lieuwe D. J. Bos,W. Joost Wiersinga,Hessel Peters‐Sengers,Tom van der Poll	5
9	The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up 2023 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·(unknown),L.S. Boers,Justin de Brabander,(unknown),(unknown),Robert F. J. Kullberg,(unknown),Tamara Dekker,Hella L. Aberson,Lilian J. Meijboom,Alexander P. J. Vlaar,Leo Heunks,Esther J. Nossent,Tom van der Poll,Lieuwe D. J. Bos,JanWillem Duitman	4
10	Thrombocytopenia is associated with a dysregulated host response in severe COVID-19 2023 ·Thrombosis Research ·Brent Appelman,(unknown),Justin de Brabander,Hessel Peters‐Sengers,Rombout B. E. van Amstel,(unknown),(unknown),(unknown),Osoul Chouchane,Alex R. Schuurman,Tom D. Y. Reijnders,Renée A. Douma,Lieuwe D. J. Bos,W. Joost Wiersinga,Tom van der Poll	2
11	Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia 2023 ·Journal of Clinical Immunology ·Quentin Philippot,Arnaud Fekkar,Adrian Gervais,Tom Le Voyer,L.S. Boers,(unknown),Lucy Bizien,Justin de Brabander,JanWillem Duitman,Alessia Romano,Jérémie Rosain,Marion Blaize,Mélanie Migaud,(unknown),(unknown),(unknown),Astrid Marchal,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),D. Sène,(unknown),(unknown),(unknown),(unknown),(unknown),Anne Puel,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	18
12	Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients 2022 ·European Respiratory Journal ·Justin de Brabander,(unknown),(unknown),Patrick Smeele,Hessel Peters‐Sengers,JanWillem Duitman,Jurjan Aman,Harm Jan Bogaard,Tom van der Poll,Lieuwe D. J. Bos	19
13	Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome 2022 ·American Journal of Respiratory and Critical Care Medicine ·Robert F. J. Kullberg,Justin de Brabander,L.S. Boers,(unknown),Esther J. Nossent,Leo Heunks,Alexander P. J. Vlaar,Peter I. Bonta,Tom van der Poll,JanWillem Duitman,Lieuwe D. J. Bos,W. Joost Wiersinga	28
14	The host response in different aetiologies of community-acquired pneumonia 2022 ·EBioMedicine ·Alex R. Schuurman,Tom D. Y. Reijnders,Tjitske S. R. van Engelen,Valentine Léopold,Justin de Brabander,(unknown),Michiel Schinkel,(unknown),Bastiaan W. Haak,Xanthe Brands,(unknown),Inge A. H. van den Berk,Renée A. Douma,Daniel Faber,Prabath W.B. Nanayakkara,Jaap Stoker,Jan M. Prins,Brendon P. Scicluna,W. Joost Wiersinga,Tom van der Poll	17
15	The Platelet Lipidome Is Altered in Patients with COVID-19 and Correlates with Platelet Reactivity 2022 ·Thrombosis and Haemostasis ·Alex R. Schuurman,Valentine Léopold,(unknown),Osoul Chouchane,Tom D. Y. Reijnders,Justin de Brabander,Renée A. Douma,Michel van Weeghel,Eric Wever,(unknown),Frédéric M. Vaz,W. Joost Wiersinga,Cornelis van’t Veer,Tom van der Poll	19
16	A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals 2021 ·JAC-Antimicrobial Resistance ·Ralalicia Limato,Erni Juwita Nelwan,(unknown),Justin de Brabander,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Raph L Hamers	30
17	Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia 2021 ·eLife ·Alex R. Schuurman,Tom D. Y. Reijnders,Anno Saris,(unknown),Michiel Schinkel,Justin de Brabander,(unknown),Louis Vermeulen,Brendon P. Scicluna,W. Joost Wiersinga,Felipe A. Vieira Braga,Tom van der Poll	10
18	Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock 2020 ·PLoS ONE ·(unknown),Mina Karami,Krischan D. Sjauw,Annemarie E. Engström,Dagmar M. Ouweneel,Justin de Brabander,Marije M. Vis,Joanna J. Wykrzykowska,Marcel A.M. Beijk,Karel T. Koch,Jan Baan,Robbert J. de Winter,Jan J. Piek,Antoine H.G. Driessen,Wim K. Lagrand,Alexander P. J. Vlaar,Jan Paul Ottervanger,José P.S. Henriques	13
19	Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience 2018 ·European Heart Journal Acute Cardiovascular Care ·Dagmar M. Ouweneel,Justin de Brabander,Mina Karami,Krischan D. Sjauw,Annemarie E. Engström,Marije M. Vis,Joanna J. Wykrzykowska,Marcel A.M. Beijk,Karel T. Koch,Jan Baan,Robbert J. de Winter,Jan J. Piek,Wim K. Lagrand,Thomas G. V. Cherpanath,Antoine H.G. Driessen,Riccardo Cocchieri,Bas A.J.M. de Mol,Jan G.P. Tijssen,José P.S. Henriques	57
20	The protective effect of behavioral activation on the growth of a syngeneic tumor and mortality in socially stressed mice 1989 ·The European Journal of Psychiatry ·B. De Brabander,(unknown),M. De Brabander,(unknown),R. Van Ginckel,Justin de Brabander	1

About Justin de Brabander

Justin de Brabander is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Biological Psychiatry, having authored 21 papers that have together received 270 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Respiratory viral infections research (4 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (29 citations), Emergency Medicine (53 citations) and Critical Care and Intensive Care Medicine (24 citations). Justin de Brabander has collaborated with scholars based in Netherlands, France and United States. Frequent co-authors include Tom van der Poll, JanWillem Duitman, Lieuwe D. J. Bos, W. Joost Wiersinga, L.S. Boers, Annemarie E. Engström, Marcel A.M. Beijk, Dagmar M. Ouweneel, Mina Karami and Alex R. Schuurman. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact